A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC) Meeting Abstract
| Authors: | Dickler, M. N.; Villanueva, R.; Fidalgo, J. A. P.; Mayer, I. A.; Boni, V.; Winer, E. P.; Hamilton, E. P.; Bellet, M.; Urruticoechea, A.; Gonzalez-Martin, A.; Cortes, J.; Martin, M.; Giltnane, J.; Gates, M.; Cheeti, S.; Fredrickson, J.; Wang, X.; Friedman, L. S.; Spoerke, J. M.; Metcalfe, C.; Liu, L.; Li, R.; Morley, R.; McCurry, U.; Chan, I. T.; Mueller, L.; Milan, S.; Lauchle, J.; Humke, E. W.; Bardia, A. |
| Abstract Title: | A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC) |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402270 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-PD5-10 |
| Notes: | Meeting Abstract: PD5-10 -- Source: Wos |
